This is a working overview of Lyophilized powder, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-08-01 and is reviewed periodically as new material appears.
Dihexa is a synthetic peptide whose structure is modeled on angiotensin IV. Its chemical name often appears as N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, though vendor and publication naming can differ. The molecule combines a short amino acid sequence with a hexanoic acid group and an amide terminus. It is classed as a small research peptide rather than a conventional drug. Databases may list it under several synonyms, so matching names are important when comparing sources.
The angiotensin IV connection places dihexa in a family of short peptides studied for effects on central nervous system signaling. Angiotensin IV itself is a metabolite of angiotensin II, and analogs have been explored in cardiovascular and neurological research. Dihexa differs from the natural peptide through structural modifications intended to alter stability and receptor interactions. Published descriptions sometimes call it a hepatocyte growth factor mimetic, although that label reflects proposed activity rather than a confirmed clinical mechanism.
Dihexa is a synthetic compound studied in laboratory and animal models for effects on synaptic connectivity and cognitive performance. It is often described as a peptide analog because its structure incorporates amino acid residues linked to a hexanoic acid group. The molecule is not a naturally occurring human hormone or neurotransmitter. Its name appears in research literature and online discussions, but it has not been approved as a medicine by major regulatory agencies. Most information comes from preclinical experiments rather than controlled human trials.
The compound originated from work on angiotensin IV, a peptide fragment of the renin-angiotensin system. Researchers modified angiotensin IV-related structures to produce molecules with altered stability and activity. Dihexa emerged from that effort and was reported to promote dendritic spine growth in cultured neurons. Some studies link its effects to hepatocyte growth factor signaling and the c-Met receptor, while other work points to insulin-regulated aminopeptidase. The precise primary target remains a subject of investigation, and findings may depend on cell type, assay conditions, and species.
In animal research, dihexa has been administered through several routes, and reports describe improved performance on spatial learning and memory tasks in rodents. These results are frequently cited in discussions of nootropic compounds. However, species differences, small sample sizes, and varied testing protocols limit how far the findings can be generalized. No large randomized controlled trials in humans have established efficacy or long-term safety. Claims about human cognitive enhancement therefore remain speculative, and the compound is best described as an experimental laboratory substance rather than a proven therapeutic or supplement.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic peptide analog | Modeled on angiotensin IV; not a natural hormone. |
| Common synonyms | Dihexa; N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide | Naming conventions differ across vendors and papers. |
| CAS Registry Number | 1401708-83-6 | Listed in some chemical databases; verify against primary sources. |
| Appearance | White to off-white powder | Typical form for lyophilized research peptides. |
| Solubility | Soluble in DMSO; limited in water | Organic stock solutions are common in laboratory settings. |
Identity and purity of dihexa samples are typically assessed with high-performance liquid chromatography and mass spectrometry. These methods can confirm molecular mass and estimate the presence of impurities. However, a certificate of analysis from a supplier is not a guarantee of independent testing. Researchers often require in-house verification before using a peptide in experiments. For solid samples, appearance, solubility, and chromatographic profile provide additional checks. Nuclear magnetic resonance may be used for structural confirmation when available.
Dihexa is commonly handled as a lyophilized powder in laboratory settings. Storage at -20 °C in a desiccated, light-protected container is typical for peptides. Repeated freeze-thaw cycles can degrade the material, so aliquoting is often recommended. Aqueous solutions may be less stable than organic stocks and should be prepared fresh when possible. Personnel should follow institutional safety procedures and avoid uncontrolled exposure. Because human effects are not well characterized, handling precautions are prudent.
Quality control usually combines reverse-phase high-performance liquid chromatography with mass spectrometry. Chromatography estimates purity and detects related impurities, while mass spectrometry supports molecular identity. Nuclear magnetic resonance can provide additional structural confirmation when needed. Stability data for dihexa are limited, and degradation pathways may depend on pH, temperature, and moisture. Open questions include long-term stability in different formulations and the effect of repeated freeze-thaw cycles on measured purity. Such tests help confirm that a batch matches its label before use.
In laboratory settings, dihexa is typically handled as a lyophilized peptide powder. Appropriate personal protective equipment and a ventilated workspace are standard practices for weighing and transferring research chemicals. Because the compound lacks regulatory approval for clinical use, it should not be given to people. Institutional safety rules and local regulations govern its acquisition, storage, and disposal. Suppliers often provide a certificate of analysis that lists purity, identity, and batch-specific handling notes.
Dissolution depends on the peptide’s salt form, purity, and the chosen solvent. Dimethyl sulfoxide is commonly used to prepare concentrated stock solutions, while aqueous buffers may show limited solubility. Sonication or gentle warming can sometimes aid dissolution, but excessive heat may promote degradation. Once in solution, the material is generally kept cold and protected from light. Researchers should verify solubility for each lot rather than assuming uniform behavior across suppliers.
The compound has been examined in animal models for effects on learning, memory, and synaptic connectivity. Some reports describe increased dendritic spine density and improved performance on certain behavioral tasks after administration in rodents. These findings are often cited in discussions of nootropic research peptides, but replication across independent laboratories remains limited. The absence of published phase 1 or phase 2 clinical trial data makes it difficult to assess safety, effective routes, or long-term outcomes in humans. Consequently, claims about cognitive benefits in people remain speculative.
Dihexa is not approved as a medicine in major regulatory jurisdictions. It is commonly sold as a research chemical for laboratory use, though such products may not be standardized or independently verified. Scientific literature on dihexa includes in vitro assays, rodent studies, and reviews that discuss its proposed mechanism. The distinction between peer-reviewed findings and commercial promotion is important when evaluating available information. Open questions include its precise binding interactions, pharmacokinetics, and whether animal results translate to human biology.
The proposed mechanism for dihexa centers on hepatocyte growth factor, or HGF, and its receptor c-Met. HGF signaling is involved in cell growth, survival, and synapse formation. Dihexa has been described as an HGF mimetic or modulator in preclinical literature. Whether it binds c-Met directly, increases HGF availability, or acts through another route remains uncertain. This mechanistic uncertainty is a recurring theme in reviews of the compound, and no single molecular model has been confirmed across independent laboratories.
Research on dihexa has primarily used rodent models and cultured cells. Common endpoints include dendritic spine density, synaptic protein expression, and performance on maze or avoidance tasks. Some studies report improvements in cognitive measures after scopolamine-induced deficits or in aged animals. These findings are interesting but come from a small body of work, and independent laboratories have not consistently replicated all reported effects. Larger, preregistered studies would help clarify which results are robust.
=== Other controversies === Starbucks has also faced criticism over its continued operations in countries with poor human rights records, particularly China. In 2024, a shareholder proposal called for greater disclosure of the company's human rights risks and dependence on China, citing concerns about the country's human rights record. The proposal was rejected by shareholders. Starbucks has also faced scrutiny over labor conditions on farms in its Chinese supply chain, including allegations of excessive working hours and child labor, which the company said it would investigate. In 2025, a court ordered Starbucks to pay $50 million to a driver who suffered burns after an unsecured hot drink spilled on him. On Red Cup Day, Starbucks provides reusable cups to customers who buy holiday-themed beverages. On Red Cup Day 2025, Starbucks employees organized a walkout at 4 p.m. local time in over a dozen U.S. cities as part of a strike known as the Red Cup Riot, involving approximately 1,000 baristas. This phase of the strike includes participation from more than 65 locations across over 40 cities. The baristas are advocating for enhanced wages, better working conditions, and reliable and adequate hours. In 2026, Starbucks Korea, which is operated by the Shinsegae Group in South Korea, released a promotion for "Tank Day" coffee tumblers, which was criticized for evoking memories of the Gwangju Uprising in 1980 and the 1987 death by torture of student activist Park Jong-chul, leading to nationwide boycotts and protests.
The autopsy report of the Office of the Medical Investigator of New Mexico noted that "the decedent did not have a regular physician and no medical records, particularly electrocardiograms or blood pressure readings were available for review" and "the best determination is that of unclassified cardiomyopathy which resulted in a cardiac dysrhythmia during exertion." However, Dr. James O'Keefe Jr., the director of Preventative Cardiology Fellowship Program and the Director of Preventative Cardiology at Cardiovascular Consultants at the Saint Luke's Mid America Heart Institute, a large cardiology practice in Kansas City, looked at the pathology report and believes that Micah True's enlarged thickened heart with scar tissue is a pathology some extreme endurance athletes develop termed Phidippides cardiomyopathy by Peter A. McCullough in research conducted with Justin E. Trivax. According to McCullough and Trivax's hypothesis, "this pathology occurs because endurance sports call for a sustained increase in cardiac output for several hours" which puts the heart "into a state of volume overload.
The presence of ANAs in blood can be confirmed by a screening test. Although there are many tests for the detection of ANAs, the most common tests used for screening are indirect immunofluorescence and enzyme-linked immunosorbent assay (ELISA). Following detection of ANAs, various subtypes are determined.
Sources: en.wikipedia.org
According to Osborne, the game's maps had "imaginative texturing and dramatic lighting effects", but pointed out that they were too dark sometimes. Wolfe felt that the environmental textures were realistic enough. Critics appreciated the realistic weapon sound effects, with Osborne writing that they made guns "viscerally fun to shoot". Wolfe agreed, but wished "the same amount of attention to detail was given to the rest of the sound in the game". He felt that the crashing thunder was flat and pointed out that footsteps didn't vary based on the surface being walked on. Dodson felt that the animations were dated, but were "nothing to scoff at". Hiles commented that the character model animations needed improvement.
=== Water isotopes and climate === Based on the processes that fractionate isotopes in the water cycle, isotopic composition of meteoric water can be used to infer related environmental variables such as air temperature, precipitation amount, past elevations, lake levels, as well as to trace moisture sources. These studies form the field of isotope hydrology. Examples of isotope hydrology applications include:
After its victory in the October 1982 elections, the PSOE remained in power for almost fourteen years. It confirmed its absolute majority in the following two elections (1986 and 1989) and from 1993, although it lost it, it remained the most voted party and was able to continue governing thanks to the support of other groups. During this extended period, the consolidation of the Spanish democracy occurred, and Spain became a society fully comparable to that of its European neighbors.
Injury in plants is damage caused by other organisms or by the non-living (abiotic) environment to plants. Animals that commonly cause injury to plants include insects, mites, nematodes, and herbivorous mammals; damage may also be caused by plant pathogens including fungi, bacteria, and viruses. Abiotic factors that can damage plants include heat, freezing, flooding, lightning, ozone gas, and pollutant chemicals. Plants respond to injury by signalling that damage has occurred, by secreting materials to seal off the damaged area, by producing antimicrobial chemicals, and in woody plants by regrowing over wounds.
Sources: en.wikipedia.org
Dihexa is a synthetic peptide analog related to angiotensin IV. It is studied in preclinical research for effects on neural signaling and synapse formation. It is not an approved medicine.
No. Dihexa shares a conceptual link to angiotensin IV but has different structural features. Those changes are intended to modify its behavior in biological systems.
It often appears as N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide. Synonyms and CAS listings vary, so cross-checking identifiers is necessary.
Dihexa is a synthetic peptide-like compound studied primarily in preclinical models. It is often classified as an angiotensin IV analog and has been investigated for effects on neuronal connectivity. It is not an approved drug or dietary supplement.